A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence

scientific article published on 01 March 1989

A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0022-5347(17)40890-1
P698PubMed publication ID2645420

P2093author name stringM F Sarosdy
D E Novicki
C H Hudnall
T C Hardin
D R Erickson
P433issue3
P407language of work or nameEnglishQ1860
P921main subjecterectile dysfunctionQ184674
alprostadilQ579348
P304page(s)551-553
P577publication date1989-03-01
P1433published inJournal of UrologyQ15709979
P1476titleA prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence
P478volume141

Reverse relations

cites work (P2860)
Q33542536Comparative tolerability and efficacy of treatments for impotence
Q35715087Impotence in elderly men.
Q41094741Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction
Q40754275Intracavernous prostaglandin E1 in erectile dysfunction
Q24247137Prostaglandin E1 for treatment of erectile dysfunction
Q87333423[Conservative therapy of erectile dysfunction]

Search more.